Eckert & Ziegler, parent company of radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products, achieved record sales from ongoing business operations in 2010.
The company reported sales of 111 million euros ($155.4 million U.S.) in 2010, a 10% gain compared with 101 million euros ($141.4 million U.S.) in 2009.
Profit after tax and minority interests rose by 26% to 9.4 million euros ($13.2 million U.S.) last year, compared with 7.5 million euros ($10.5 million U.S.) in 2009, according to the firm.
Eckert & Ziegler forecasted sales of 110 million euros ($154 million U.S.) to 120 million euros ($168 million U.S.) for 2011.
